Physician profile
David Kao
NPI 1225526544
$24,127.75
in general payments reported to CMS, 2019-2025
8 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22K · 2024: $1,683 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Food and Beverage: $2,233 · Travel and Lodging: $1,870 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Food and Beverage | $2,232.76 |
| Travel and Lodging | $1,869.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,099.11 | 2023-2024 | |
| Stryker Corporation | $896.08 | 2023-2024 | Gamma, T2, Ortholoc 2 Lapifuse |
| Fortis Surgical, LLC | $564.33 | 2023-2025 | |
| Depuy Synthes Sales INC. | $256.68 | 2023-2024 | Healix Knotless Peek, Vivigen Mis Delivery System, Fibergraft Bg Morsels |
| Exactech, INC. | $164.17 | 2024 | |
| Vericel Corporation | $79.47 | 2025 | Maci |
| Smith+Nephew, INC. | $42.91 | 2023 | Q-Fix, Microraptor, Novostitch |
| Becton, Dickinson and Company | $25.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.